{"title":"Enhancing antimicrobial stewardship through IT-enabled audits: a quasi-experimental study in urology.","authors":"Kartik Bhagat, Kavita Diddi, Adel Alsisi, Mohammed Zaqout, Shyam Mohan, Shanmugavalli Ganesan, Jithin Antony, Touseef Sulaimani","doi":"10.1017/ash.2025.10212","DOIUrl":"10.1017/ash.2025.10212","url":null,"abstract":"<p><strong>Background: </strong>Antimicrobial stewardship programs (ASPs) are critical for optimizing antibiotic use and addressing antimicrobial resistance (AMR). Urinary tract infections (UTIs) frequently require antibiotics, yet inappropriate prescribing remains high.</p><p><strong>Objective: </strong>To assess how a structured audit process, supported by information technology (IT), influences antibiotic prescribing practices for UTIs in the Urology Department at Prime Hospital.</p><p><strong>Design: </strong>A 12-month quasi-experimental study was conducted in two phases: preintervention and intervention. A customized module in the electronic medical record (EMR) system monitored UTI prescriptions. Alerts for restricted antibiotics were reviewed daily by the antimicrobial stewardship (AMS) team, with immediate feedback to prescribers. The audit emphasized adherence to empirical guidelines, reducing fluoroquinolone use, promoting Access group antibiotics, and minimizing restricted agents.</p><p><strong>Patients: </strong>All adult UTI patients in the Urology Department were included; pediatric patients under 12 and pregnant women were excluded.</p><p><strong>Results: </strong>The intervention improved guideline adherence increased the use of Access group antibiotics and reduced restricted antibiotic prescriptions by approximately 50%. Daily multidisciplinary feedback reinforced rational prescribing; however, sustaining long-term behavioral change remained challenging.</p><p><strong>Conclusion: </strong>Despite growing awareness of AMR, inappropriate antibiotic use persists. IT-enabled audits, combined with multidisciplinary collaboration, effectively enhance guideline adherence, promote rational antibiotic use, and improve patient care outcomes in hospital-based UTI management.</p>","PeriodicalId":72246,"journal":{"name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","volume":"5 1","pages":"e342"},"PeriodicalIF":0.0,"publicationDate":"2026-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12766517/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145913924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Resistance-guided therapy and integration of novel therapeutics are key to facilitating antimicrobial stewardship for sexually transmitted infections.","authors":"Lao-Tzu Allan-Blitz, Jeffrey D Klausner","doi":"10.1017/ash.2026.10940","DOIUrl":"https://doi.org/10.1017/ash.2026.10940","url":null,"abstract":"","PeriodicalId":72246,"journal":{"name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","volume":"6 1","pages":"e354"},"PeriodicalIF":0.0,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13744940/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149382049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ivayla I Geneva, Kayode Medugbon, Stephen J Thomas, Andrea Call
{"title":"An evaluation of piperacillin-tazobactam antimicrobial stewardship intervention and association with β-lactam susceptibility in <i>Pseudomonas aeruginosa</i> and <i>Enterobacter cloacae</i> complex.","authors":"Ivayla I Geneva, Kayode Medugbon, Stephen J Thomas, Andrea Call","doi":"10.1017/ash.2026.10911","DOIUrl":"https://doi.org/10.1017/ash.2026.10911","url":null,"abstract":"<p><strong>Introduction: </strong>Antimicrobial resistance is a growing global concern. At our hospital, susceptibility of Pseudomonas aeruginosa to piperacillin-tazobactam declined from 95% to 77%, while susceptibility of Enterobacter cloacae complex decreased from 82% to 72%, prompting antimicrobial stewardship program (ASP) interventions.</p><p><strong>Methods: </strong>ASP interventions aimed to reduce unnecessary antipseudomonal therapy with ceftriaxone recommended for low-risk patients, to replace piperacillin-tazobactam with cefepime in high-risk patients. Additionally, pharmacodynamic optimization was introduced for piperacillin-tazobactam, cefepime, and ceftriaxone. Annual inpatient antibiograms and antibiotic use (days of therapy per 1,000 patient-days) were evaluated for piperacillin-tazobactam, cefepime, meropenem, ciprofloxacin, levofloxacin, and ceftriaxone. Spearman correlation assessed the relationship between antibiotic use and bacterial susceptibility with a 1-year lag.</p><p><strong>Results: </strong>Over the two years following the initiation of interventions in 2023, piperacillin-tazobactam use decreased 11-fold, cefepime use increased 2.6-fold, and ceftriaxone use increased by 1.7-fold. Meropenem use declined 1.5-fold. P. aeruginosa susceptibility improved: piperacillin-tazobactam (77% to 96%), meropenem (83% to 92%), and cefepime (77% to 96%). E. cloacae complex susceptibility to piperacillin-tazobactam increased from 63% to 86%. Piperacillin-tazobactam use demonstrated a statistically significant perfect negative correlation with P. aeruginosa susceptibility. Cefepime use showed a strong positive, non-significant correlation with P. aeruginosa susceptibility, whereas the correlation between piperacillin-tazobactam use and E. cloacae susceptibility was moderately negative but not significant.</p><p><strong>Conclusions: </strong>ASP-driven restriction of piperacillin-tazobactam was associated with marked improvement in P. aeruginosa susceptibility to both piperacillin-tazobactam and cefepime despite substantially increased cefepime use, suggesting shared resistance mechanisms and that piperacillin-tazobactam may be a major driver of resistance selection.</p>","PeriodicalId":72246,"journal":{"name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","volume":"6 1","pages":"e341"},"PeriodicalIF":0.0,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13760292/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149413462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Regev Cohen, Shelly Lipman-Arens, Yael Galnoor-Tene, Linor Ishay, Olga Feld-Simon, Orna Ben-Natan, Aliza Vaknin, Mohammed Ganayem, Yana Tal, Limor Rabinovitch, Milena Pitashny, Elias Tannous, Maanit Shapira
{"title":"Feasibility of conditional urine culture based on pathological urinalysis: a retrospective diagnostic stewardship study.","authors":"Regev Cohen, Shelly Lipman-Arens, Yael Galnoor-Tene, Linor Ishay, Olga Feld-Simon, Orna Ben-Natan, Aliza Vaknin, Mohammed Ganayem, Yana Tal, Limor Rabinovitch, Milena Pitashny, Elias Tannous, Maanit Shapira","doi":"10.1017/ash.2026.10906","DOIUrl":"https://doi.org/10.1017/ash.2026.10906","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate urinalysis (UA) performance for identifying single-uropathogen bacteriuria, characterize positive cultures after normal UA, compare laboratory and point-of-care platforms, and explore the resource implications of conditional culture.</p><p><strong>Methods: </strong>We retrospectively analyzed nonduplicate urine-culture episodes linked to same-day UA at a tertiary hospital in 2024. Pathological UA was defined as positive leukocyte esterase or nitrite. Diagnostic performance was assessed against single-uropathogen growth versus culture-negative reports. Selected culture-positive episodes underwent chart review. An exploratory model estimated resource use under a symptom- and UA-guided culture pathway.</p><p><strong>Results: </strong>Among 9,036 eligible culture episodes from 8,214 patients, 4,273 (47.3%) had same-day UA. The primary cohort comprised 3,969 episodes, including 925 single-uropathogen cases and 3,044 culture-negative controls. Pathological UA had 92.8% sensitivity (95% confidence interval, 91.1%-94.4%), 51.5% specificity (49.7%-53.2%), 36.8% positive predictive value (34.8%-38.7%), and 95.9% negative predictive value (94.9%-96.9%). Of 92 reviewed positive cultures after normal UA, 77 (83.7%) were classified as asymptomatic bacteriuria; seven of the remaining 15 episodes were adjudicated as probable urinary tract infection. The base-case model projected direct laboratory costs of $31,900 versus $102,700, with substantial variation across eligibility assumptions.</p><p><strong>Conclusions: </strong>Most positive cultures after normal UA represented asymptomatic bacteriuria, while culture-positive probable urinary tract infection was rare. These findings support a symptom-informed, UA-guided strategy with clinical overrides.</p>","PeriodicalId":72246,"journal":{"name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","volume":"6 1","pages":"e340"},"PeriodicalIF":0.0,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13760299/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149413534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Evaluation of healthcare workers' compliance with contact isolation precautions and associated factors in pediatric and pediatric surgery intensive care units.","authors":"Gülsüm İclal Bayhan, Leeyan Alghoosen, Yazan Darwish, Lara Maraqa, Esra Koçkuzu, Vildan Selin Çayhan, Ümran Erden, Nurdan Kaykı Aksoy, Serhat Emeksiz","doi":"10.1017/ash.2026.10902","DOIUrl":"https://doi.org/10.1017/ash.2026.10902","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate healthcare workers' (HCWs) adherence to contact precautions (CP) in pediatric intensive care settings and to identify factors associated with compliance.</p><p><strong>Design: </strong>Prospective observational study.</p><p><strong>Setting: </strong>Pediatric intensive care units (PICUs) and a pediatric surgical intensive care unit (PSCU) at a tertiary care hospital.</p><p><strong>Participants: </strong>Healthcare workers involved in patient care activities in PICUs and PSCU.</p><p><strong>Methods: </strong>HCWs were directly observed during patient care procedures. Adherence to CP measures was evaluated using a five-step checklist, and compliance levels were categorized as low, moderate, or high. Associations between compliance and potential influencing factors were analyzed.</p><p><strong>Results: </strong>A total of 367 observations were performed. High compliance was observed in 30.4% of procedures, moderate compliance in 54.2%, and low compliance in 15.4%. Compliance levels were significantly associated with professional category and ICU unit, whereas no significant association was found with the type of patient care activity or microorganism type.</p><p><strong>Conclusions: </strong>Compliance with CP was suboptimal and varied according to professional category and ICU unit. These findings suggest that adherence is influenced by both individual and unit-level factors. Targeted, context-specific interventions and continuous education may improve adherence to infection control measures.</p>","PeriodicalId":72246,"journal":{"name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","volume":"6 1","pages":"e333"},"PeriodicalIF":0.0,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13760302/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149413531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Anjali Susan Silby, Trusha Nana, Vindana Chibabhai, Michelle Lowe, Teena Thomas
{"title":"Colistin-resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i> in a South African tertiary-level hospital (2022-2024): a retrospective data analysis.","authors":"Anjali Susan Silby, Trusha Nana, Vindana Chibabhai, Michelle Lowe, Teena Thomas","doi":"10.1017/ash.2026.10889","DOIUrl":"https://doi.org/10.1017/ash.2026.10889","url":null,"abstract":"<p><strong>Objectives: </strong>The growing incidence of colistin resistance in <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i> is a cause for concern. This study aimed to determine the epidemiological characteristics of colistin resistance in <i>A. baumannii</i> and <i>K. pneumoniae</i> clinical isolates from a tertiary-level hospital in Johannesburg, South Africa.</p><p><strong>Methods: </strong>A retrospective data analysis was done on data retrieved from the Corporate Data Warehouse, National Health Laboratory Services from 1 January 2022 to 30 June 2024.</p><p><strong>Results: </strong>Of 2 900 <i>A. baumannii</i> and <i>K. pneumoniae</i> isolates, 830 underwent colistin broth microdilution (BMD) testing, with 22% (186/830) confirmed to be colistin-resistant. Colistin minimum inhibitory concentrations (MICs) ≥16μg/mL occurred in 75% of isolates. <i>Klebsiella pneumoniae</i> accounted for 63% (117/186) of the resistant isolates. Overall, 62% (116/186) of resistant isolates were extensively drug-resistant (XDR). Adult intensive care units (ICUs) contributed 45% (84/186) of resistant isolates.</p><p><strong>Conclusion: </strong>Colistin resistance in <i>A</i>. <i>baumannii</i> and <i>K</i>. <i>pneumoniae</i> presents a significant threat in South Africa's healthcare settings. The high proportion of resistant isolates in ICUs and of XDR phenotypes highlight the urgent need for coordinated antimicrobial stewardship (AMS) and infection prevention and control (IPC) interventions. Stronger AMS, IPC and surveillance are vital to slow this threat and preserve the effectiveness of last-line therapies.</p>","PeriodicalId":72246,"journal":{"name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","volume":"6 1","pages":"e332"},"PeriodicalIF":0.0,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13760415/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149413515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"AI in antimicrobial stewardship: time to involve patients?","authors":"Neda Milevska-Kostova","doi":"10.1017/ash.2026.10914","DOIUrl":"https://doi.org/10.1017/ash.2026.10914","url":null,"abstract":"<p><p>Artificial intelligence is transforming antibiotic stewardship but largely overlooks the patient perspectives shaping prescribing decisions. Because inappropriate antibiotic use is fundamentally relational, AI must incorporate patient narratives, communication, and shared decision-making alongside clinical data. Patient-centered AI could improve prescribing, trust, adherence, and global efforts to combat antimicrobial resistance sustainably.</p>","PeriodicalId":72246,"journal":{"name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","volume":"6 1","pages":"e335"},"PeriodicalIF":0.0,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13760224/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149413461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gugulethu Julia Phambane, Sinenhlanhla Ndzabandzaba, Joy Fredericks, Rispah Chomba
{"title":"Extensively drug-resistant <i>Acinetobacter baumannii</i> complex (ABC) colonization and clinical outcomes in neonates in a tertiary hospital, South Africa: 2020-2022.","authors":"Gugulethu Julia Phambane, Sinenhlanhla Ndzabandzaba, Joy Fredericks, Rispah Chomba","doi":"10.1017/ash.2026.10879","DOIUrl":"https://doi.org/10.1017/ash.2026.10879","url":null,"abstract":"<p><strong>Background: </strong>Extensively drug-resistant <i>Acinetobacter baumannii</i> (XDR-AB) is a significant cause of healthcare-associated infections, particularly in neonatal intensive care units. This study aimed to determine the prevalence of XDR-AB colonization and the odds of subsequent invasive infection. The secondary objectives were to identify risk factors and in-hospital outcomes.</p><p><strong>Methods: </strong>A retrospective study was conducted among 485 neonates admitted to Rahima Moosa Mother and Child Hospital in Johannesburg, South Africa, from June 1, 2020 to December 31, 2022, using laboratory data and medical records.</p><p><strong>Results: </strong>Among 485 neonates, 116 babies (23.9%) were colonized with XDR-AB, with a median colonization age of 4 days. A total of 32 neonates developed invasive infections. Invasive XDR-AB disease was significantly more common among colonized neonates (29 neonates (25%)) compared to 3 (0.81%) non-colonized neonates. In-hospital mortality was significantly higher in colonized neonates (12 (10.34%)) compared to non-colonized neonates (5 cases (1.36%)). Other in-hospital outcomes were not significantly associated with colonization status. Independent colonization risk factors were all affected by confounding.</p><p><strong>Conclusions: </strong>This study highlights the high prevalence of early colonization and subsequent invasive disease with its associated mortality in neonates. Screening of neonates for early colonization helps in empiric antibiotic choices for those found to be colonized.</p>","PeriodicalId":72246,"journal":{"name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","volume":"6 1","pages":"e329"},"PeriodicalIF":0.0,"publicationDate":"2026-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13760411/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149413533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cumulative antibiogram at a tertiary cancer center in Jordan showing alarming antimicrobial resistance trends.","authors":"Sawsan Mubarak, Iyad Sultan, Osama Abu Ata, Omar Khresat, Hadeel AlGhawrie","doi":"10.1017/ash.2026.10888","DOIUrl":"https://doi.org/10.1017/ash.2026.10888","url":null,"abstract":"<p><strong>Objective: </strong>Multidrug-resistant (MDR) bacteria poses a significant threat to patient care, especially in vulnerable populations. This study evaluates antimicrobial resistance (AMR) trends at a tertiary cancer center in Jordan, analyzing data from 2007 to 2022.</p><p><strong>Design and settings: </strong>This retrospective study analyzed 51,697 first bacterial isolates from 108,432 cultures at King Hussein Cancer Center (2007-2022). Data were stratified into three periods and processed using the AMR package for R. Binomial logistic regression models were employed to forecast resistance trends to 2030.</p><p><strong>Results: </strong>The comprehensive analysis of 51,697 first bacterial isolates revealed that 61% were Gram-negative bacteria (GNB) and 39% were Gram-positive bacteria (GPB), with <i>Escherichia coli</i>, coagulase-negative <i>staphylococci</i> (CoNS), and <i>Klebsiella pneumonia</i> predominating. MDR was identified in 36.5% of isolates, with GNB accounting for 84.4%, while extensively drug-resistant (XDR) was confined to <i>Acinetobacter baumannii</i>-calcoaceticus and <i>Pseudomonas aeruginosa</i>. Conversely, nonfermenting GNB showed declining resistance trajectories for piperacillin/tazobactam and amikacin. Among Gram-positives, methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) surged from 37% to 57%. Vancomycin-resistant <i>enterococci</i> (VRE) increased reaching 13%. Blood cultures were predominantly GPB (65%), while respiratory and urine samples were primary sources of resistant GNB. Hematologic malignancy patients exhibited the highest extensively drug-resistant (XDR) rates (5.6%-7.9%) and VRE burden (32% in leukemia). Predictive models forecast escalations by 2030: MRSA 72.7%, VRE in <i>Enterococcus faecium</i> 70%, and cefepime resistance in <i>Enterobacterales</i> 61.9%.</p><p><strong>Conclusion: </strong>Our AMR patterns are alarming and vary significantly by specimen site and cancer diagnosis, underscoring the urgent need for enhanced stewardship, infection control, and diagnosis-specific empirical protocols.</p>","PeriodicalId":72246,"journal":{"name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","volume":"6 1","pages":"e311"},"PeriodicalIF":0.0,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13760307/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149413516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}